Anand Padmanabhan
Company: Retham Technologies
Job title: President and Chief Science Officer
Seminars:
1:45 pm Off-the-shelf RethamTM Platelets for Assessment of Platelet Activation by Therapeutic IgG mAb Drug Candidates 1:45 pm
Platelet activation induced by IgG monoclonal antibodies can significantly increase risk for adverse thrombotic events. Evaluation of the potential for induction of platelet activation by therapeutic IgG mabs can be challenging, requiring fresh healthy-donor platelets, and sensitive activation readouts. Long-term stored RethamTM platelets that have intact FcGRIIa signaling, developed using recent breakthrough technology, can be…Read more
day: Conference Day One